SPEKCITON BIOSCIENCES LLC

Biotech · Private

Real-time optical inspection system for plant foliage that predicts pharmaceutical protein production and detects plant stress in molecular farming crops

Grants
$255K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Biophotonic plant foliage optical inspection system for improved indoor molecular farming of plant-based medicines$255,482
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3005Provivi Inc.—$77M
3006REVERSAL THERAPEUTICS INC——
3007EARNANO, LLC——
3008SPEKCITON BIOSCIENCES LLC——
3009MONTANA MOLECULAR, LLC——
3010ARGOS VISION INC.——
3011BACSTITCH DNA INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Duvf-msi Biophotonic Analyzer Device And Methods For Detecting Pathogens On Plants And Measuring Stress Responseapplication
  • Duvf-msi Biophotonic Analyzer Device And Methods For Detecting Pathogens On Plants And Measuring Stress Responseapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.